Related Experiment Video

Updated: Aug 6, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

[Optimized regional lymph node management after neoadjuvant therapy in breast cancer]

P F Qiu1, X W Wang1, Y S Wang1

  • 1Department of Breast Surgery, Shandong Cancer Hospital and Institute, Jinan 250117, China Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan 250118, China.

Zhonghua Yi Xue Za Zhi
|July 21, 2026
PubMed
Summary

Neoadjuvant therapy (NAT) enables de-escalation of axillary surgery for breast cancer patients. For select cases, omitting axillary surgery or radiotherapy is becoming feasible, with future AI and ctDNA guiding decisions.

More Related Videos

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

Related Concept Videos